Home » Newsletters » BioWorld Science

BioWorld Science

April 19, 2018

View Archived Issues

Cystic Fibrosis Foundation TDN endorses phase II study protocol for PTI-428

Tecentriq launched in Japan for the treatment of unresectable advanced or recurrent NSCLC

AiCuris and Max Planck to identify novel compounds for treatment of viral and bacterial infections

Bayer presents a novel SMYD3 inhibitor probe

First subject dosed in phase I/IIa trial of SYNB-1618 for the treatment of phenylketonuria

AntoXa Corporation obtains license from DRDC for plant-made PhD9 anti-ricin antibody

Artelo Biosciences licenses IP portfolio of fatty acid binding protein inhibitors

Preclinical evaluation of novel HERA-LIGHT fusion protein for cancer immunotherapy

FDA grants fast track designation CB-839 in combination with cabozantinib for treatment of RCC

Caspid modulator GLP-26 shows promise for drug-resistant hepatitis B virus infection

AstraZeneca launches Lynparza in Japan

Fasenra for asthma now available in Japan

FDA approves Tagrisso for first-line NSCLC

AstraZeneca and Daiichi Sankyo launch new formulation of Nexium

Taiho presents highly selective RET inhibitor TAS-0286

Opiant Pharmaceuticals receives grant to develop intranasal nalmefene

Mercaptor develops new class of drugs called captons

Cancer Research Technology patents new CDC7 inhibitors

Cellipse identifies LIMK-1 and/or LIMK-2 inhibitors

Procter & Gamble to acquire Merck KGaA's consumer health business

FDA grants priority review to sBLA for Opdivo in previously treated SCLC

Institut Pasteur Korea divulges new compounds for influenza

Pear Therapeutics and Sandoz sign agreement for prescription digital therapeutics

Novel compound targets multiple immune checkpoint elements

New EHMT1 and/or EHMT2 inhibitors presented by Epizyme

Boehringer Ingelheim patents hSTING agonists

FDA grants rare pediatric disease designation to sevuparin for children with sickle cell disease

Qu Biologics initiates phase II trial for QBECO in Crohn's disease

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...